Metabolization of human milk oligosaccharides by Streptococcus pneumoniae
Open Access
- 30 September 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
It is unclear whether human milk oligosaccharides (HMOs) can be used as a nutrient source by Streptococcus pneumoniae . Here, we investigate whether and how S. pneumoniae metabolizes HMOs and whether these compounds inhibit pneumococcal adherence. We find that S. pneumoniae can metabolize several HMOs, except for 2’-fucosyllactose (2’FL). The process is regulated by the carbon catabolite repression system. Transcriptome analyses showed reduced expression of the lac operon I ( lacABCD ) in bacteria grown with two tested HMOs when compared to lactose (Lac). Genes for the Leloir pathway and exoglycosidases were upregulated. A genome-wide CRISPR interference screen showed that the lac operons I and II ( lacEFG-2 ) are essential for metabolizing HMOs. Lac and non-metabolizable 2’FL were found to inhibit pneumococcal adherence to host cells in vitro. Importantly, 2’FL showed a stronger inhibitory effect compared to Lac in vivo. Further research is warranted to investigate whether the non-metabolizable 2’FL can be used to inhibit pneumococcal adherence.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030-236265)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P500PB_225439)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_192517)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_200792)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (NCCR 51NF40_180541)
- Medical Research Council (MR/X009130/1)
This publication has 67 references indexed in Scilit:
- Dual CRISPRi-seq for genome-wide genetic interaction studies identifies key genes involved in the pneumococcal cell cycleCell Systems, 2025
- Systemic Availability of Human Milk Oligosaccharides in Infants and Adults: A Narrative ReviewAdvances in Nutrition, 2025
- Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysisThe Lancet Infectious Diseases, 2024
- Streptococcus pneumoniae carriage, serotypes, genotypes, and antimicrobial resistance trends among children in Portugal, after introduction of PCV13 in National Immunization Program: A cross-sectional studyVaccine, 2024
- Exploration of Bacterial Bottlenecks and Streptococcus pneumoniae Pathogenesis by CRISPRi-SeqCell Host & Microbe, 2020
- Glycan‐metabolizing enzymes in microbe–host interactions: the Streptococcus pneumoniae paradigmFEBS Letters, 2018
- Studies on the Chemical Nature of the Substance Inducing Transformation of Pneumococcal Types2017
- Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in SwitzerlandVaccine, 2017
- Carbon catabolite repression in bacteriaCurrent Opinion in Microbiology, 1999
- Receptor specificity of adherence of Streptococcus pneumoniae to human type-II pneumocytes and vascular endothelial cells in vitroMicrobial Pathogenesis, 1994